- Home
- Industry Reports
- Biotechnology
- Healthcare
- Asia Pacific Precision Medicine Market – Size, Outlook, Trends, and Forecast (2024 – 2032)
Precision medicine is an emerging medical approach that helps in the treatment by providing customised medicine based on their medical decisions, practices, and allows doctors and physicians to study the individual response to a medication. This medicine will allow researchers and doctors to estimate accurately to prevent various diseases. Initially, precision medicine is focused on oncology, like cancer, it is one of the significant causes of death globally with an increase in ageing population.
The Asia Pacific Precision Medicine Market Segments Size & Growth:
The Asia Pacific precision medicine market is accounted for $8.96billion in 2017 and expected to grow at a CAGR of 12.8% to reach $16.1 billion by 2024 during the forecast period 2018-2024. Major factors that are driving the market growth owing to the adoption of gene therapy, number of chronic diseases, and improvements in big data analytics. However, high cost for customised medicine and misinterpretation of genetic data hinder the growth of the Asia Pacific precision medicine market.
The Asia Pacific Precision Medicine Market Segments Share:
The Asia Pacific precision medicine market is categorised into by type of technology which consists of bioinformatics, gene sequencing, big data analytics, drug discovery, and companion diagnosis. Drug discovery has the most significant share due to the increase of chronic diseases such as cancer, diabetes, and so on. By application, Precision Medicine market is segmented as immunology, neurology, respiratory, and CNS. Among all oncology are expected to have high growth rate during the forecast period 2018-2024, because of increase in cancer cases.
By Geography, China is dominating the precision medicine market, and the growth in the Asia Pacific is mainly attributed because of the increasing demand for personalised medicine and rise in diseases. Furthermore, India is witnessing the fastest growth during the forecast period, due to rising ageing population, chronic diseases and investment in R&D research.
The Asia Pacific Precision Medicine Market SegmentsTrends:
- In January 2018, treatment for breast cancer through personalised medicine has been discovered by the University of Alberta researchers which can form cancer cell susceptible to the treatment.
- In January 2017, Qiagen has wholly acquired OmicSoft Corporation to access data management solution.
The Asia Pacific Precision Medicine Research Report:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
- Regional and the global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
- Identifying DROC in the current market and their impact in altering the market dynamics.
- Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Eagle Genomics
- Ferrer InCode
- Medtronic
- Teva Pharmaceutical
- Covance Inc.
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2Porter’s five force analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1. Drivers
4.1.1 Adoption of gene therapy
4.1.2 Increase in chronic diseases
4.1.3 Improvements in big data analytics
4.2 Restraints
4.2.1 Cost of personalised medicine
4.2.2 Misinterpretation of genetic data
4.3 Opportunities
4.3.1 New therapeutic targets
4.3.2 Understanding of how cancer defect immune system.
4.4 Challenges
4.4.1.Advancement of pharmacogenomics
Chapter 5 Asia Pacific Precision Market – By Type of Technology
5.1 Bioinformatics
5.2 Gene Sequencing
5.3 Big Data Analytics
5.4 Companion Diagnostics
5.5 Drug Discovery
Chapter 6 Asia PacificPrecision Market – By Application
6.1 Immunology
6.2 Respiratory
6.3 Neurology
6.4 CNS
6.5 Oncology
Chapter 7 Asia PacificPrecision Market – By Geography
7.1 Introduction
7.2 Asia Pacific
7.2.1. China
7.2.2. India
7.2.3. Japan
7.2.3. South Korea
7.2.5. Australia & New Zealand
7.2.6. Rest of APAC
Chapter 8 Asia Pacific Precision Market – Company Profiles
8.1. Pfizer
8.2.BIOCRATES Life Sciences AG
8.3Nanostring Technologies
8.4.Roche Diagnostics
8.5.Eagle Genomics
8.6. Ferrer InCode
8.7.Medtronic
8.8.Teva Pharmaceutical
8.9.Covance Inc.
8.10.Silicon Biosystems
8.11.QIAGEN Inc.
8.12.Novartis Holding AG.
8.13.Laboratory Corporation of America Holdings
8.14.Tepnel Pharma Services
8.15.Intomics
Chapter 9 Asia Pacific Precision Market – Competitive Landscape
9.1.Market Share Analysis
9.2.Strategies Adopted by top companies
9.3.Mergers, Acquisitions, Collaborations & Agreements
Chapter 10 Market Insights
10.1. Industry Experts Insights
10.2. Analysts Opinions
10.3. Investment Opportunities
Chapter 11 Appendix
11.1 List of Tables
11.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Regional Report
$2,160.00 – $7,200.00
- EUR: €2,022.66 - €6,742.20
- INR: ₹180,397.12 - ₹601,323.72
- AED: د.إ7,927.20 - د.إ26,424.00
- GBP: £1,731.96 - £5,773.21
Description
Regional Reports
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
Precision medicine is an emerging medical approach that helps in the treatment by providing customised medicine based on their medical decisions, practices, and allows doctors and physicians to study the individual response to a medication. This medicine will allow researchers and doctors to estimate accurately to prevent various diseases. Initially, precision medicine is focused on oncology, like cancer, it is one of the significant causes of death globally with an increase in ageing population.
The Asia Pacific Precision Medicine Market Segments Size & Growth:
The Asia Pacific precision medicine market is accounted for $8.96billion in 2017 and expected to grow at a CAGR of 12.8% to reach $16.1 billion by 2024 during the forecast period 2018-2024. Major factors that are driving the market growth owing to the adoption of gene therapy, number of chronic diseases, and improvements in big data analytics. However, high cost for customised medicine and misinterpretation of genetic data hinder the growth of the Asia Pacific precision medicine market.
The Asia Pacific Precision Medicine Market Segments Share:
The Asia Pacific precision medicine market is categorised into by type of technology which consists of bioinformatics, gene sequencing, big data analytics, drug discovery, and companion diagnosis. Drug discovery has the most significant share due to the increase of chronic diseases such as cancer, diabetes, and so on. By application, Precision Medicine market is segmented as immunology, neurology, respiratory, and CNS. Among all oncology are expected to have high growth rate during the forecast period 2018-2024, because of increase in cancer cases.
By Geography, China is dominating the precision medicine market, and the growth in the Asia Pacific is mainly attributed because of the increasing demand for personalised medicine and rise in diseases. Furthermore, India is witnessing the fastest growth during the forecast period, due to rising ageing population, chronic diseases and investment in R&D research.
The Asia Pacific Precision Medicine Market SegmentsTrends:
- In January 2018, treatment for breast cancer through personalised medicine has been discovered by the University of Alberta researchers which can form cancer cell susceptible to the treatment.
- In January 2017, Qiagen has wholly acquired OmicSoft Corporation to access data management solution.
The Asia Pacific Precision Medicine Research Report:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
- Regional and the global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
- Identifying DROC in the current market and their impact in altering the market dynamics.
- Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Eagle Genomics
- Ferrer InCode
- Medtronic
- Teva Pharmaceutical
- Covance Inc.
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2Porter’s five force analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1. Drivers
4.1.1 Adoption of gene therapy
4.1.2 Increase in chronic diseases
4.1.3 Improvements in big data analytics
4.2 Restraints
4.2.1 Cost of personalised medicine
4.2.2 Misinterpretation of genetic data
4.3 Opportunities
4.3.1 New therapeutic targets
4.3.2 Understanding of how cancer defect immune system.
4.4 Challenges
4.4.1.Advancement of pharmacogenomics
Chapter 5 Asia Pacific Precision Market – By Type of Technology
5.1 Bioinformatics
5.2 Gene Sequencing
5.3 Big Data Analytics
5.4 Companion Diagnostics
5.5 Drug Discovery
Chapter 6 Asia PacificPrecision Market – By Application
6.1 Immunology
6.2 Respiratory
6.3 Neurology
6.4 CNS
6.5 Oncology
Chapter 7 Asia PacificPrecision Market – By Geography
7.1 Introduction
7.2 Asia Pacific
7.2.1. China
7.2.2. India
7.2.3. Japan
7.2.3. South Korea
7.2.5. Australia & New Zealand
7.2.6. Rest of APAC
Chapter 8 Asia Pacific Precision Market – Company Profiles
8.1. Pfizer
8.2.BIOCRATES Life Sciences AG
8.3Nanostring Technologies
8.4.Roche Diagnostics
8.5.Eagle Genomics
8.6. Ferrer InCode
8.7.Medtronic
8.8.Teva Pharmaceutical
8.9.Covance Inc.
8.10.Silicon Biosystems
8.11.QIAGEN Inc.
8.12.Novartis Holding AG.
8.13.Laboratory Corporation of America Holdings
8.14.Tepnel Pharma Services
8.15.Intomics
Chapter 9 Asia Pacific Precision Market – Competitive Landscape
9.1.Market Share Analysis
9.2.Strategies Adopted by top companies
9.3.Mergers, Acquisitions, Collaborations & Agreements
Chapter 10 Market Insights
10.1. Industry Experts Insights
10.2. Analysts Opinions
10.3. Investment Opportunities
Chapter 11 Appendix
11.1 List of Tables
11.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.